Skip to content

AI Assisted Reader Evaluation in Acute Computed Tomography (CT) Head Interpretation

AI Assisted Reader Evaluation in Acute CT Head Interpretation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06018545
Acronym
AI-REACT
Enrollment
33
Registered
2023-08-30
Start date
2023-06-01
Completion date
2025-06-01
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Hemorrhages, Acute Ischemic Stroke, Hydrocephalus, Cerebral Infarction, Cerebral Edema, Cerebral Injury

Keywords

Radiology, Head tomography, Emergency medicine, Radiographer, Artificial intelligence

Brief summary

This study has been added as a sub study to the Simulation Training for Emergency Department Imaging 2 study (ClinicalTrials.gov ID NCT05427838). The purpose of the study is to assess the impact of an Artificial Intelligence (AI) tool called qER 2.0 EU on the performance of readers, including general radiologists, emergency medicine clinicians, and radiographers, in interpreting non-contrast CT head scans. The study aims to evaluate the changes in accuracy, review time, and diagnostic confidence when using the AI tool. It also seeks to provide evidence on the diagnostic performance of the AI tool and its potential to improve efficiency and patient care in the context of the National Health Service (NHS). The study will use a dataset of 150 CT head scans, including both control cases and abnormal cases with specific abnormalities. The results of this study will inform larger follow-up studies in real-life Emergency Department (ED) settings.

Interventions

Two Consultant neuroradiologists will independently review the images to establish the 'ground truth' findings on the CT scans which will be used as the reference standard. In the case of disagreement, a third senior neuroradiologist's opinion will be sought for arbitration.

OTHERReading

All 30 readers will review all 150 cases, in each of two study phases. The readers will provide their opinion on the presence or absence of some acute abnormalities, including intracranial haemorrhage, infarct, midline shift and fracture. They will provide a confidence in their diagnosis (10-point visual analogue scale), and a single click point to mark the location of each abnormality that they consider as being present. The time taken for each scan will be automatically recorded.

Sponsors

Oxford University Hospitals NHS Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Radiologists/Radiographers/ED clinicians who review CT head scans as part of their clinical practice

Exclusion criteria

* Neuroradiologists. * Non-radiologist groups: Clinicians with previous formal postgraduate CT reporting training * Emergency Medicine group: Clinicians with previous career in radiology/neurosurgery to registrar level

Design outcomes

Primary

MeasureTime frameDescription
Reader speed: Mean time taken to review a scan, with versus without AI assistance.During 6 weeks, which is the period for reading or reviewing the cases/scans.Reader speed will be evaluated as the man time taken to review a scan, using time unite of seconds.
Reader performance: Sensitivity, specificity, comparative between with and without AI assistance.During 6 weeks, which is the period for reading or reviewing the cases/scans.Reader performance will be evaluated as sensitivity, specificity, with and without AI assistance.
Reader performance: Positive and negative predictive value, comparative between with and without AI assistance.During 6 weeks, which is the period for reading or reviewing the cases/scans.Reader performance will be evaluated as Positive Predictive Value (PPV) and negative predictive value (NPV), with and without AI assistance.
Reader performance: Area Under Receiver Operating Characteristic Curve (AUROC), comparative between with and without AI assistance.During 6 weeks, which is the period for reading or reviewing the cases/scans.Reader performance will be evaluated as Area Under Receiver Operating Characteristic Curve (AUROC), with and without AI assistance.
Reader confidence: Self-reported diagnostic confidence on a 10 point visual analogue scale, with vs without AI assistance.During 6 weeks, which is the period for reading or reviewing the cases/scans.On the reading platform (RAIQC), one of the questions asks the level of confidence that the participant has in their diagnostic opinion. The question offers a scale of 1 to 10, where 1 is not confident, and 10 is highly confident.
qER (AI algorithm) performance: Sensitivity and specificityDuring 6 weeks, which is the period for reading or reviewing the cases/scans.qER performance will be evaluated as sensitivity, specificity.
qER (AI algorithm) performance: Positive and negative predictive value.During 6 weeks, which is the period for reading or reviewing the cases/scans.qER performance will be evaluated as Positive Predictive Value (PPV) and negative predictive value (NPV).
qER (AI algorithm) performance: Area Under Receiver Operating Characteristic Curve (AUROC).During 6 weeks, which is the period for reading or reviewing the cases/scans.qER performance will be evaluated as Area Under Receiver Operating Characteristic Curve (AUROC)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026